This grant is for the purpose of supporting hybrid effectiveness-implementation trials targeting heart, lung, blood, and sleep (HLBS) diseases in inpatient settings. The NHLBI seeks applications testing implementation strategies from established frameworks to increase evidence-based practice adoption. This aims to improve HLBS patient care by integrating proven interventions into clinical routines. Applicants must propose a multidisciplinary team with expertise in inpatient clinical research, implementation science, and biostatistics. All eligible applicants are encouraged to apply for this opportunity to advance practical HLBS applications.
Opportunity ID: 327707
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-HL-21-001 |
| Funding Opportunity Title: | Hybrid Effectiveness-Implementation Trials for Heart, Lung, Blood, and Sleep Diseases in the Inpatient Setting (U01 – Clinical Trials Required) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.233 — National Center on Sleep Disorders Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jun 15, 2020 |
| Last Updated Date: | Jun 15, 2020 |
| Original Closing Date for Applications: | Dec 09, 2020 |
| Current Closing Date for Applications: | Dec 09, 2020 |
| Archive Date: | Jan 14, 2021 |
| Estimated Total Program Funding: | $2,512,000 |
| Award Ceiling: | $400,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | State governments Special district governments Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts Public and State controlled institutions of higher education Small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Public housing authorities/Indian housing authorities Private institutions of higher education Native American tribal governments (Federally recognized) For profit organizations other than small businesses County governments Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this Funding Opportunity Announcement (FOA) is to support hybrid effectiveness-implementation trials for heart, lung, blood, and sleep (HLBS) diseases in the inpatient setting. NHLBI is seeking applications that propose a trial testing an implementation strategy (or strategies) that was developed utilizing an implementation research framework and that aims to increase implementation of an evidence-based practice(s). This FOA intends to support applications that propose a multidisciplinary research team that includes expertise in inpatient clinical research, implementation research, and biostatistics. Any applicant proposing a trial that meets the requirements of this FOA is eligible to apply, regardless of participation in Planning Hybrid Effectiveness-Implementation Trials for Heart, Lung, Blood, and Sleep Diseases in the Inpatient Setting (U34) (RFA-HL-18-018). |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-21-001.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-F | Use for due dates on or after May 25, 2020 | PKG00262211 | Nov 09, 2020 | Dec 09, 2020 | View |
Package 1
Mandatory forms
327707 RR_SF424_2_0-2.0.pdf
327707 PHS398_CoverPageSupplement_5_0-5.0.pdf
327707 RR_OtherProjectInfo_1_4-1.4.pdf
327707 PerformanceSite_2_0-2.0.pdf
327707 RR_KeyPersonExpanded_2_0-2.0.pdf
327707 PHS398_ResearchPlan_4_0-4.0.pdf
327707 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
327707 RR_Budget_1_4-1.4.pdf
327707 RR_SubawardBudget30_1_4-1.4.pdf
327707 PHS398_ModularBudget_1_2-1.2.pdf
327707 PHS_AssignmentRequestForm_3_0-3.0.pdf